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Crimean-Congo hemorrhagic fever (CCHF) is caused by infection with a tick-borne virus (Nairovirus) in the family Bunyaviridae. The 
disease was first characterized in the Crimea in 1944 and given the name Crimean hemorrhagic fever. It was then later recognized in 
1969 as the cause of illness in the Congo, thus resulting in the current name of the disease. 
Crimean-Congo hemorrhagic fever is found in Eastern Europe, particularly in the former Soviet Union, throughout the Mediterranean, in 
northwestern China, central Asia, southern Europe, Africa, the Middle East, and the Indian subcontinent. 
Transmission 
Ixodid (hard) ticks, especially those of the genus, Hyalomma, are both a reservoir and a vector for the CCHF virus.  Numerous wild and 
domestic animals, such as cattle, goats, sheep and hares, serve as amplifying hosts for the virus. Transmission to humans occurs through 
contact with infected ticks or animal blood. CCHF can be transmitted from one infected human to another by contact with infectious 
blood or body fluids. Documented spread of CCHF has also occurred in hospitals due to improper sterilization of medical equipment, 
reuse of injection needles, and contamination of medical supplies. 
Signs and Symptoms 
The onset of CCHF is sudden, with initial signs and symptoms including headache, high fever, back pain, joint pain, stomach pain, and 
vomiting.  Red eyes, a flushed face, a red throat, and petechiae (red spots) on the palate are common.  Symptoms may also include 
jaundice, and in severe cases, changes in mood and sensory perception. 
As the illness progresses, large areas of severe bruising, severe nosebleeds, and uncontrolled bleeding at injection sites can be seen, 
beginning on about the fourth day of illness and lasting for about two weeks. In documented outbreaks of CCHF, fatality rates in 
hospitalized patients have ranged from 9% to as high as 50%. 
The long-term effects of CCHF infection have not been studied well enough in survivors to determine whether or not specific 
complications exist. However, recovery is slow. 
Risk of Exposure 
Animal herders, livestock workers, and slaughterhouse workers in endemic areas are at risk of CCHF. Healthcare workers in endemic 
areas are at risk of infection through unprotected contact with infectious blood and body fluids. Individuals and international travelers 
with contact to livestock in endemic regions may also be exposed. 
Diagnosis 
Laboratory tests that are used to diagnose CCHF include antigen-capture enzyme-linked immunosorbent assay (ELISA), real time 
polymerase chain reaction (RT-PCR), virus isolation attempts, and detection of antibody by ELISA (IgG and IgM).  Laboratory diagnosis of 
a patient with a clinical history compatible with CCHF can be made during the acute phase of the disease by using the combination of 
detection of the viral antigen (ELISA antigen capture), viral RNA sequence (RT-PCR) in the blood or in tissues collected from a fatal case 
and virus isolation. Immunohistochemical staining can also show evidence of viral antigen in formalin-fixed tissues.  Later in the course 
of the disease, in people surviving, antibodies can be found in the blood. But antigen, viral RNA and virus are no more present and 
detectable. 
Treatment 
Treatment for CCHF is primarily supportive.  Care should include careful attention to fluid balance and correction of electrolyte 
abnormalities, oxygenation and hemodynamic support, and appropriate treatment of secondary infections. The virus is sensitive in vitro 
to the antiviral drug ribavirin.  It has been used in the treatment of CCHF patients reportedly with some benefit. 
Recovery 
The long-term effects of CCHF infection have not been studied well enough in survivors to determine whether or not specific 
complications exist. However, recovery is slow. 
Prevention 
Agricultural workers and others working with animals should use insect repellent on exposed skin and clothing. Insect repellants 
containing DEET (N, N-diethyl-m-toluamide) are the most effective in warding off ticks.  Wearing gloves and other protective clothing is 
recommended. Individuals should also avoid contact with the blood and body fluids of livestock or humans who show symptoms of 
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